Series: Off-label drug sales increase

11/3/2003

In a three-part series, Knight Ridder investigates the rise of off-label drug uses, whereby specialty drugs are prescribed for non-approved uses, sometimes with dangerous side effects. Part 1 discusses side effects suffered by some patients, and Part 2 investigates the marketing of medications to health care professionals for non-approved uses.

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ